The immunohistochemical expression of hormone receptors such as the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is a widely accepted and commonly used classification system for breast cancer [101,102,103]. This evidence concerns the gene NR4A1 and breast cancer.